Versant Venture Management, LLC

Q3 2026 13F-HR Holdings

Location
San Francisco, CA
Holdings as of
9/30/2026
Date filed
11/13/2026
Form type
13F-HR
Num holdings
8
Total value ($000)
$109,097
Net value change ($000)
-53,516 (-32.9%)
New positions
1
Sold out positions
1
Turnover %
1.6%
Sector allocation + QoQ delta (equities-only)
Prev filing: 8/12/2026 Next filing: — SEC filing

Snapshot: Change Analysis

Compared to Q2 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
CTNM 8,453 95.0%
Skye Bioscience, Inc. 404 NEW
CRSP 116 1.4%
Top Reduces (Value $000, Stocks/ETFs)
GLUE -39,028 -50.7%
IPSC -9,003 -30.2%
JBIO -8,102 -36.8%
LENZ -4,889 -32.4%
SKYE -1,392 -100.0%
TPST -74 -24.7%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type